Cancer Medicines Pathfinder
Submitted by Anonymous (not verified) on 28 October 2024 - 13:07
Cancer Medicines Pathfinder
Cancer Medicines Pathfinder
Cancer Medicines Forum
Cancer medicines
Medical devices: expert panel advice at the request of the Medical Device Coordination Group and the European Commission
List of signals discussed at PRAC since September 2012
PSUSA/00003090/202401
PSUSA/00010374/202401
Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of argininosuccinic aciduria, 17/07/2013 Positive
Orphan designation: Humanised anti-folate receptor 1 monoclonal antibody conjugated to maytansinoid DM4 Treatment of ovarian cancer, 19/03/2015 Positive
Orphan designation: Heterologous human adult liver-derived progenitor cells Treatment of ornithine-translocase deficiency, 17/07/2013 Positive